Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $121.06M.
ENTERPRISE VALUE (EV)
$121.06M
TuHURA Biosciences, Inc.
Market Cap
$124.18M
Enterprise Value (EV)
$121.06M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| TuHURA Biosciences, Inc. (HURA) | $124.18M | $121.06M |
| Entera Bio Ltd. (ENTX)vs › | $124.70M | $113.82M |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | N/A |
| BGM Group Ltd. (BGM)vs › | $122.43M | $112.09M |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.29M | $101.85M |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | $112.83M |
| Seer, Inc. (SEER)vs › | $120.41M | $116.72M |
| Pyxis Oncology, Inc. (PYXS)vs › | $127.98M | $126.96M |
| Cibus, Inc. (CBUS)vs › | $119.84M | $132.15M |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.83M | $94.75M |
Market Cap
$124.18M
Total Debt
$500981.00
Cash
$3.62M
Enterprise Value
$121.06M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
